148 related articles for article (PubMed ID: 36637268)
21. Intraneural perineurioma in neurofibromatosis type 2 with molecular analysis.
White B; Belzberg A; Ahlawat S; Blakeley J; Rodriguez FJ
Clin Neuropathol; 2020; 39(4):167-171. PubMed ID: 32271143
[TBL] [Abstract][Full Text] [Related]
22. Focal amyotrophy in neurofibromatosis 2.
Trivedi R; Byrne J; Huson SM; Donaghy M
J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):257-61. PubMed ID: 10896706
[TBL] [Abstract][Full Text] [Related]
23. An update on the CNS manifestations of neurofibromatosis type 2.
Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective.
Shinya Y; Teranishi Y; Hasegawa H; Miyawaki S; Sugiyama T; Shin M; Kawashima M; Umekawa M; Katano A; Nakatomi H; Saito N
J Neurooncol; 2024 Jan; 166(1):185-194. PubMed ID: 38151698
[TBL] [Abstract][Full Text] [Related]
25. Malignant peripheral nerve sheath tumors arising from schwannomas: case series and literature review.
Berner EA; Hung YP; Nielsen GP; Lozano-Calderón SA
APMIS; 2021 Aug; 129(8):524-532. PubMed ID: 34050984
[TBL] [Abstract][Full Text] [Related]
26. Neurological outcomes and surgical complications in 221 spinal nerve sheath tumors.
Safaee MM; Lyon R; Barbaro NM; Chou D; Mummaneni PV; Weinstein PR; Chin CT; Tihan T; Ames CP
J Neurosurg Spine; 2017 Jan; 26(1):103-111. PubMed ID: 27472744
[TBL] [Abstract][Full Text] [Related]
27. Clinical results after surgical resection of benign solitary schwannomas: A review of 150 cases.
El Sayed L; H Masmejean E; Lavollé A; Biau D; Peyre M
Orthop Traumatol Surg Res; 2022 Jun; 108(4):103281. PubMed ID: 35477039
[TBL] [Abstract][Full Text] [Related]
28. Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital.
Guha D; Davidson B; Nadi M; Alotaibi NM; Fehlings MG; Gentili F; Valiante TA; Tator CH; Tymianski M; Guha A; Zadeh G
J Neurosurg; 2018 Apr; 128(4):1226-1234. PubMed ID: 28686119
[TBL] [Abstract][Full Text] [Related]
29. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
[TBL] [Abstract][Full Text] [Related]
30. Foraminal nerve sheath tumors: intermediate follow-up after cyberknife radiosurgery.
Murovic JA; Gibbs IC; Chang SD; Mobley BC; Park J; Adler JR
Neurosurgery; 2009 Feb; 64(2 Suppl):A33-43. PubMed ID: 19165072
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of embedded nerve tissue in six NF2-associated schwannomas and 17 nonassociated NF2 schwannomas.
Hamada Y; Iwaki T; Fukui M; Tateishi J
Surg Neurol; 1997 Oct; 48(4):395-400. PubMed ID: 9315139
[TBL] [Abstract][Full Text] [Related]
32. Multinodular plexiform tumors of major peripheral nerves: A practical overview.
Sturdà C; Pennisi G; D'Alessandris QG; Mattogno P; Fernandez E; Granata G; Gessi M; Lauretti L
J Clin Neurosci; 2021 Nov; 93():106-111. PubMed ID: 34656232
[TBL] [Abstract][Full Text] [Related]
33. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
[TBL] [Abstract][Full Text] [Related]
34. Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors.
Hornick JL; Bundock EA; Fletcher CD
Am J Surg Pathol; 2009 Oct; 33(10):1554-61. PubMed ID: 19623031
[TBL] [Abstract][Full Text] [Related]
35. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
36. Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.
Dirks MS; Butman JA; Kim HJ; Wu T; Morgan K; Tran AP; Lonser RR; Asthagiri AR
J Neurosurg; 2012 Jul; 117(1):109-17. PubMed ID: 22503123
[TBL] [Abstract][Full Text] [Related]
37. Intramuscular peripheral nerve sheath tumors: schwannoma, ancient schwannoma, and neurofibroma.
Lee SK; Kim JY; Lee YS; Jeong HS
Skeletal Radiol; 2020 Jun; 49(6):967-975. PubMed ID: 31932870
[TBL] [Abstract][Full Text] [Related]
38. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological variables of sporadic schwannomas of peripheral nerve in 291 patients and expression of biologically relevant markers.
Young ED; Ingram D; Metcalf-Doetsch W; Khan D; Al Sannaa G; Le Loarer F; Lazar AJF; Slopis J; Torres KE; Lev D; Pollock RE; McCutcheon IE
J Neurosurg; 2018 Sep; 129(3):805-814. PubMed ID: 28885122
[TBL] [Abstract][Full Text] [Related]
40. Malignant transformation in a hybrid schwannoma/perineurioma: addition to the spectrum of a malignant peripheral nerve sheath tumor.
Rekhi B; Jambhekar NA
Indian J Pathol Microbiol; 2011; 54(4):825-8. PubMed ID: 22234123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
